["{\n\"step_by_step_thinking\": \"The question asks if PRL3-zumab can inhibit PRL3+ cancer cells both in vitro (in a laboratory setting) and in vivo (in living organisms). There are no relevant documents that directly address this topic. The provided documents describe various studies on lymphocytes, tumor cells, nude mice, and cell proliferation rates. They do not mention PRL3 or its antibody zumab. Therefore, it is not possible to determine the efficacy of PRL3-zumab based on these documents.\",\n\"answer_choice\": \"B\""]